Biogen Inc (BIIB)

Return on assets (ROA)

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Net income (ttm)	US$ in thousands	1,632,200	1,615,200	1,158,600	1,166,600	1,161,100	1,461,800	2,664,600	3,131,000	3,046,900	2,864,700	2,059,200	1,449,700	1,556,100	1,545,800	1,918,100	3,011,700	4,000,600	5,082,400	5,926,800	5,878,800
Total assets	US$ in thousands	28,049,300	28,313,200	26,804,100	26,567,600	26,844,800	28,193,200	25,156,800	24,598,400	24,554,100	24,854,200	25,081,400	23,614,400	23,877,300	23,806,700	24,470,400	23,854,700	24,618,900	24,934,100	25,511,800	26,119,200
ROA		5.82%	5.70%	4.32%	4.39%	4.33%	5.18%	10.59%	12.73%	12.41%	11.53%	8.21%	6.14%	6.52%	6.49%	7.84%	12.63%	16.25%	20.38%	23.23%	22.51%

December 31, 2024 calculation

ROA = Net income (ttm) ÷ Total assets
= $1,632,200K ÷ $28,049,300K
= 5.82%

Biogen Inc's Return on Assets (ROA) has shown a declining trend over the reported periods from a high of 23.23% in June 2020 to a low of 4.32% in June 2024. This indicates that the company's ability to generate profits from its assets has been decreasing over time. The ROA peaked in the second quarter of 2020 and has been on a gradual decline since then. Investors and stakeholders may be concerned about the company's efficiency in utilizing its assets to generate earnings. It is important for Biogen Inc to analyze the factors contributing to this decline and take necessary measures to improve its ROA in the future.